This study provides the first comprehensive molecular evidence of synergistic neuroprotective effects exerted by alpha-lipoic acid (ALA) and metformin in diabetic encephalopathy through the coordinated activation of Nrf2 and AMPK signaling pathways. This evidence concerns the gene NFE2L2 and diabetic encephalopathy.